Papers - Nakajima, Shinichiro

Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia.

Suzuki T, Uchida H, Takeuchi H, Nakajima S, Nomura K, Tanabe A, Yagi G, Watanabe K, Kashima H.

Hum Psychopharmacol.  2009

Antipsychotic-induced paroxysmal perceptual alteration in a patient with bipolar disorder.

Nakajima S, Suzuki T, Uchida H, Watanabe K, Kashima H.

Prog Neuropsychopharmacol Biol Psychiatry.  2009

Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan.

Uchida H1, Suzuki T, Mamo DC, Mulsant BH, Tsunoda K, Takeuchi H, Kikuchi T, Nakajima S, Nomura K, Tomita M, Watanabe K, Kashima H.

Psychiatry Clin Neurosci.  2009

Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: a chart review.

Nakajima S1, Ishida T, Akaishi R, Takahata K, Kitahata R, Uchida H, Suzuki T, Takeuchi H, Nomura K, Nakagawa A, Watanabe K, Kashima H.

J ECT.  2009

Selective serotonin reuptake inhibitor-induced spermatorrhea in 2 patients.

Nakajima S, Uchida H, Suzuki T, Watanabe K, Kashima H.

J Clin Psychiatry.  2009

Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone.

Suzuki T1, Uchida H, Watanabe K, Nakajima S, Nomura K, Takeuchi H, Tanabe A, Yagi G, Kashima H.

Hum Psychopharmacol.  2008

A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering.

Takeuchi H1, Suzuki T, Uchida H, Nakajima S, Nomura K, Kikuchi T, Manki H, Watanabe K, Kashima H.

J Clin Psychopharmacol.  2008

Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz).

Suzuki T1, Uchida H, Nomura K, Takeuchi H, Nakajima S, Tanabe A, Yagi G, Watanabe K, Kashima H.

Schizophr Res.  2008

An open-label trial of discontinuing benzodiazepines in patients with chronic schizophrenia.

Nakajima S, Uchida H, Suzuki T, Tomita M, Tsunoda K, Kitta M, Takeuchi H, Nomura K, Watanabe K, Kashima H.

J Clin Psychopharmacol. J Clin Psychopharmacol.  2007

Bone mineral density measurement in female inpatients with schizophrenia.

Kishimoto T, Watanabe K, Takeuchi H, Kikuchi T, Nakajima S, Shimada N, Yagi G, Kashima H.

Schizophr Res.  2005